/Companies

Asylia Therapeutics

Houston, US · Founded 2019 · Delaware corporation

Find your way into Asylia Therapeutics

Sign up to see every warm intro you have to Asylia Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Asylia Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

JK
Joseph KekstNamed on SEC filing
EE
Elan EzicksonNamed on SEC filing
JG
Jeno GyurisNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$8.2M disclosed across 1 round · 2021

▶$8.2MraisedMar 2021 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joseph KekstDirector
  • Elan EzicksonExecutive Officer, Director
  • Jeno GyurisExecutive Officer, Director
Offering amount
$16.2M
Amount sold
$8.2M
First sale
Feb 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Asylia Therapeutics raised?
Asylia Therapeutics has disclosed $8.2M raised across 1 round.
Where is Asylia Therapeutics headquartered?
Asylia Therapeutics is headquartered in Houston, US.